Abstract Details

Title haMSter: a Smartphone Application for Remote Patient Monitoring

Topic Multiple Sclerosis

Presentation(s) P18 - Poster Session 18 (5:30 PM-6:30 PM)

Poster/Presentation
Number 12-003

Background Continuous monitoring of patient reported outcomes (PROs) as part of remote patient monitoring (RPM) provides great insights into health-related quality of life in patients with MS (pwMS).

Objective To test a smartphone application named haMSter that enables tracking of PROs in a real world setting.

Design/Methods

haMSter provides three PRO questionnaires to be filled out once a month over a period of six months. These include the Hospital Anxiety and Depression Scale (HADS), the Multiple Sclerosis Impact Scale (MSIS-29), and the Fatigue Scale for Motor and Cognitive Function (FSMC). Through the use of the haMSter app, longitudinal and remote measurement of validated PROs is enabled. A scoring algorithm graphically plots PRO scores over time and makes them available at the next visit to be discussed with the treating neurologist. We report the percentage of filled out questionnaires over the study period and satisfaction with this method based on results from the Telemedicine Perception Questionnaire (TMPQ, min: 17; max: 85 points).

Results 30 patients completed this study so far. The median age was 34 years (IQR: 25-39), median EDSS was 2.5 (IQR 1-3.5) and 53% were female. Overall, 89% of questionnaires were fillet out, suggesting high adherence. The mean score on the TMPQ was 72 (95%CI: 68-79) which translates as high satisfaction with this method).

Conclusions The haMSter app is a reliable m-health solution through which PROs can be monitored longitudinally.

Authors/Disclosures
Patrick Altmann (Univ.-Klinik für Neurologie) PRESENTER	The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Markus Ponleitner	No disclosure on file
Fritz Leutmezer	Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Tobias Monschein (Medizinische Universität Wien / Universitätsklinik für Neurologie)	No disclosure on file
Paulus S. Rommer (AKH Wien / Univ. Klinik Fuer Neurologie)	Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Thomas A. Berger, MD (Dept. of Neurology, Medical University of Vienna)	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Gabriel Bsteh, MD (Medical University Vienna, Department of Neurology)	Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene-BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme.